Titre : Virus parainfluenza de type 5

Virus parainfluenza de type 5 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Computer Simulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virus parainfluenza de type 5 : Questions médicales les plus fréquentes", "headline": "Virus parainfluenza de type 5 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virus parainfluenza de type 5 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-18", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virus parainfluenza de type 5" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Rubulavirus", "url": "https://questionsmedicales.fr/mesh/D019213", "about": { "@type": "MedicalCondition", "name": "Rubulavirus", "code": { "@type": "MedicalCode", "code": "D019213", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.480.937.600.650.750" } } }, "about": { "@type": "MedicalCondition", "name": "Virus parainfluenza de type 5", "alternateName": "Parainfluenza Virus 5", "code": { "@type": "MedicalCode", "code": "D045402", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Biao He", "url": "https://questionsmedicales.fr/author/Biao%20He", "affiliation": { "@type": "Organization", "name": "Department of Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States of America." } }, { "@type": "Person", "name": "Keisuke Ohta", "url": "https://questionsmedicales.fr/author/Keisuke%20Ohta", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan." } }, { "@type": "Person", "name": "Machiko Nishio", "url": "https://questionsmedicales.fr/author/Machiko%20Nishio", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: mnishio@wakayama-med.ac.jp." } }, { "@type": "Person", "name": "Yusuke Matsumoto", "url": "https://questionsmedicales.fr/author/Yusuke%20Matsumoto", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Medicine, Wakayama Medical University, Wakayama, Japan." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36063219", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00894-022-05142-7" } }, { "@type": "ScholarlyArticle", "name": "Left ventricular venting in veno-arterial extracorporeal membrane oxygenation: A computer simulation study.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35903013", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03913988221115444" } }, { "@type": "ScholarlyArticle", "name": "Computational simulations reveal that Abl activity controls cohesiveness of actin networks in growth cones.", "datePublished": "2022-07-20", "url": "https://questionsmedicales.fr/article/35857718", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1091/mbc.E21-11-0535" } }, { "@type": "ScholarlyArticle", "name": "High Performance Computing Simulation of Intelligent Logistics Management Based on Shortest Path Algorithm.", "datePublished": "2022-06-08", "url": "https://questionsmedicales.fr/article/35720907", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/7930553" } }, { "@type": "ScholarlyArticle", "name": "Comparisons of computer simulations and experimental data for capacitive hyperthermia using different split-phantoms.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428108", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/02656736.2024.2416999" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Virus à ARN de polarité négative", "item": "https://questionsmedicales.fr/mesh/D000086103" }, { "@type": "ListItem", "position": 5, "name": "Mononegavirales", "item": "https://questionsmedicales.fr/mesh/D018096" }, { "@type": "ListItem", "position": 6, "name": "Paramyxoviridae", "item": "https://questionsmedicales.fr/mesh/D010252" }, { "@type": "ListItem", "position": 7, "name": "Paramyxovirinae", "item": "https://questionsmedicales.fr/mesh/D018098" }, { "@type": "ListItem", "position": 8, "name": "Rubulavirus", "item": "https://questionsmedicales.fr/mesh/D019213" }, { "@type": "ListItem", "position": 9, "name": "Virus parainfluenza de type 5", "item": "https://questionsmedicales.fr/mesh/D045402" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virus parainfluenza de type 5 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virus parainfluenza de type 5", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virus parainfluenza de type 5", "description": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?\nQuels tests sont utilisés pour confirmer le virus parainfluenza 5 ?\nLes symptômes aident-ils au diagnostic du virus parainfluenza 5 ?\nPeut-on diagnostiquer le virus parainfluenza 5 par sérologie ?\nLes radiographies sont-elles utiles pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virus parainfluenza de type 5", "description": "Quels sont les symptômes courants du virus parainfluenza 5 ?\nLe virus parainfluenza 5 cause-t-il des complications respiratoires ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes persistent-ils longtemps ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virus parainfluenza de type 5", "description": "Comment prévenir l'infection par le virus parainfluenza 5 ?\nLes vaccins protègent-ils contre ce virus ?\nFaut-il éviter les lieux publics en cas d'épidémie ?\nLe port de masque est-il utile ?\nLes enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virus parainfluenza de type 5", "description": "Quel est le traitement principal pour le virus parainfluenza 5 ?\nDes antiviraux sont-ils efficaces contre ce virus ?\nQuand faut-il consulter un médecin ?\nLes inhalateurs sont-ils recommandés ?\nLe repos est-il important lors d'une infection ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virus parainfluenza de type 5", "description": "Quelles sont les complications possibles du virus parainfluenza 5 ?\nLes personnes âgées sont-elles plus à risque de complications ?\nLe virus peut-il aggraver des maladies préexistantes ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications si elles surviennent ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virus parainfluenza de type 5", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes maladies respiratoires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes nourrissons sont-ils plus à risque ?\nLes conditions de vie affectent-elles le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D045402?mesh_terms=Computer+Simulation&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une infection par le virus parainfluenza 5 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests PCR, cultures virales et des analyses cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer le virus parainfluenza 5 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les cultures de prélèvements respiratoires sont les plus courants." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic du virus parainfluenza 5 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques comme la toux et la fièvre orientent le diagnostic." } }, { "@type": "Question", "name": "Peut-on diagnostiquer le virus parainfluenza 5 par sérologie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La sérologie n'est pas couramment utilisée pour ce virus, les tests PCR sont préférés." } }, { "@type": "Question", "name": "Les radiographies sont-elles utiles pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les radiographies peuvent montrer des signes d'infection, mais ne confirment pas le virus." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du virus parainfluenza 5 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, fièvre, congestion nasale et difficultés respiratoires." } }, { "@type": "Question", "name": "Le virus parainfluenza 5 cause-t-il des complications respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des complications comme la bronchite ou la pneumonie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants peuvent présenter des symptômes plus graves que les adultes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez la détresse respiratoire et la fièvre élevée, surtout chez les enfants." } }, { "@type": "Question", "name": "Les symptômes persistent-ils longtemps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent durer de quelques jours à deux semaines selon la gravité." } }, { "@type": "Question", "name": "Comment prévenir l'infection par le virus parainfluenza 5 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Lavez-vous les mains régulièrement et évitez le contact avec des personnes malades." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre ce virus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin spécifique contre le virus parainfluenza 5 actuellement." } }, { "@type": "Question", "name": "Faut-il éviter les lieux publics en cas d'épidémie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les lieux bondés peut réduire le risque de transmission du virus." } }, { "@type": "Question", "name": "Le port de masque est-il utile ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter un masque peut aider à réduire la propagation des infections respiratoires." } }, { "@type": "Question", "name": "Les enfants doivent-ils être vaccinés contre d'autres virus respiratoires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre d'autres virus comme la grippe est recommandée." } }, { "@type": "Question", "name": "Quel est le traitement principal pour le virus parainfluenza 5 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, incluant des antipyrétiques et des bronchodilatateurs." } }, { "@type": "Question", "name": "Des antiviraux sont-ils efficaces contre ce virus ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour le virus parainfluenza 5." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes s'aggravent ou si la respiration devient difficile." } }, { "@type": "Question", "name": "Les inhalateurs sont-ils recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inhalateurs peuvent aider à soulager la respiration en cas de bronchospasme." } }, { "@type": "Question", "name": "Le repos est-il important lors d'une infection ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le repos aide le corps à combattre l'infection et à récupérer plus rapidement." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du virus parainfluenza 5 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la bronchite, la pneumonie et des infections secondaires." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et immunodéprimées sont plus susceptibles de développer des complications." } }, { "@type": "Question", "name": "Le virus peut-il aggraver des maladies préexistantes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut aggraver des maladies respiratoires chroniques comme l'asthme." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les jeunes enfants." } }, { "@type": "Question", "name": "Comment gérer les complications si elles surviennent ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent souvent une hospitalisation et un traitement médical intensif." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque." } }, { "@type": "Question", "name": "Les maladies respiratoires augmentent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents de maladies respiratoires sont plus vulnérables." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque d'infections respiratoires, y compris parainfluenza." } }, { "@type": "Question", "name": "Les nourrissons sont-ils plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les nourrissons ont un système immunitaire immature, les rendant plus vulnérables." } }, { "@type": "Question", "name": "Les conditions de vie affectent-elles le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre dans des environnements surpeuplés ou insalubres augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Left ventricular venting in veno-arterial extracorporeal membrane oxygenation: A computer simulation study.

Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is the fastest way to restore circulation in refractory cardiogenic shock, however it cannot unload the failing left ventricle. There is a ... A computer model was developed in Matlab Simulink R20016b (MathWorks, Inc., Natick, MA, USA) to analyze different venting options as well as atrial septostomy in the setting of cardiogenic shock and V... The model has shown an inverse linear relationship between left atrial pressure and either vent, Impella or atrial septum defect flow rate. The minimum vent flow required to prevent pulmonary edema in... Our data suggest that reduction of left atrial pressure is linearly related to the vent, Impella or atrial septal defect flow rate. The preferred vent location is the left ventricle as it avoids stasi...

Comparisons of computer simulations and experimental data for capacitive hyperthermia using different split-phantoms.

Several positive clinical trials have demonstrated that capacitive hyperthermia (CHT) improves the effectiveness of radiation therapy for the treatment of various cancer entities. However, the ability... To perform a pilot study involving comparisons of computer simulations and experimental data using different split-phantoms to validate hyperthermia treatment modeling for pre-planning for a clinical ... The CHT system EHY-2030 (Oncotherm, Budapest, Hungary) was used. The system provides two electrode sizes, but only the smaller electrode, indicated as D200 electrode, was investigated in this pilot st... For the investigated electrode D200 the system power of 75 W was applied, which is half of the maximum power of 150 W and lies in the range of usual values for this electrode applied in patient treatm... Computer simulations and experimental data were compared for the CHT system EHY-2030 using the D200 electrode, applying a thermal imaging technique for different vertically splittable phantoms. This p...